Vagner-Capodano A M, Michel G, Maraninchi D, Tubiana N, Gouzien M, Perrimond H, Carcassonne Y
Laboratoire de Génétique, Faculté de Médecine, Marseille, France.
Ann Genet. 1988;31(1):53-6.
We report a new case of childhood acute lymphoblastic leukemia with translocation (1;19). At the time of diagnosis, the only adverse prognosis factor was the existence of this translocation. Under conventional chemotherapy, the girl experienced early marrow relapse (duration of first remission was 2 months). She received allogeneic bone marrow transplantation during the second remission and is alive in continuous complete remission 20 months after transplant. Several earlier reports have suggested that children with the (1;19) have a poor prognosis; If this poor response to conventional therapy is confirmed, an allogeneic bone marrow transplantation should be considered during the first remission.
我们报告了一例伴有1;19易位的儿童急性淋巴细胞白血病新病例。诊断时,唯一的不良预后因素是存在这种易位。在传统化疗下,该女孩早期出现骨髓复发(首次缓解期为2个月)。她在第二次缓解期接受了异基因骨髓移植,移植后20个月持续完全缓解且存活。此前的几份报告表明,伴有1;19易位的儿童预后较差;如果对传统治疗的这种不良反应得到证实,应在首次缓解期考虑进行异基因骨髓移植。